Nephros Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Nephros Inc 's inventory turnover ratio sequentially decreased to 2.53 in the third quarter 2026, otherwise the ratio remained above the average, as NEPH's markets remain strong.Average processing period, for Nephros Inc 's inventories remained unchanged at 144 days, in the Sep 30 2026 quarter.

Within Healthcare sector 155 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1046 in the second quarter 2026, to 1323.

NEPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nephros Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEPH Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	80.9 %	103.26 %	85.21 %	23.59 %	-11.65 %
Y / Y Cost of Sales Growth	133.6 %	99.1 %	100 %	100 %	0 %
Inventory Turnover Ratio (TTM)	2.53	2.54	2.71	2.76	2.1
NEPH's Total Ranking	# 1323	# 1046	# 1026	# 961	#
Average inventory processing period	144	143	135	132	174
Seq. Inventory Growth	8.93 %	25.64 %	11.97 %	18.04 %	22.4 %
Seq. Cost of Sales Growth	17.33 %	-0.45 %	-50 %	300 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 64
Healthcare Sector	# 156
Overall Market	# 1323

Inventory Turnover Ratio Statistics
High	Average	Low
4.24	1.99	0.75
(Mar 31 2015)		(Mar 31 2021)

NEPH Company Profile >> Back to NEPH Efficiency Comparisons >> Compare NEPH Inventory Turnover Ratio to its Competitors

Financial Statements
Nephros Inc 's Inventories	$ 5 Millions	Visit NEPH's Balance sheet
Nephros Inc 's Cost of Revenues TTM	$ 10 Millions	Visit NEPH's Income Statement
What are NEPH's Sales?		Visit NEPH's Sales by Segment

Other Inventory Turnover Ratios
Nephros Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NEPH's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NEPH's Competitors
Inventory Turnover Ratio for NEPH's Suppliers
Inventory Turnover Ratio for NEPH's Customers

You may also want to know
NEPH's Sales Growth Rates	NEPH's Pe Price to earnings ratio	NEPH's Receivables Turnover Ratio	NEPH's Stock Quote
NEPH's Net Income Growth Rates	NEPH's Ps Price to Sales ratio	NEPH's Sales per Employee	NEPH's Asset Turnover Ratio
NEPH's Net Margin	NEPH's Pb Price to Book ratio	NEPH's Financial Strength Ratios	NEPH's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Transmedics Group Inc	5.70	$ 301.220 Millions	$ 53 Millions
Bristol myers Squibb Company	5.65	$ 15,389.000 Millions	$ 2,722 Millions
Avantor Inc	5.48	$ 4,539.200 Millions	$ 828 Millions
Tactile Systems Technology Inc	5.25	$ 82.718 Millions	$ 16 Millions
Integer Holdings Corporation	4.98	$ 1,376.268 Millions	$ 276 Millions
Ge Healthcare Technologies Inc	4.69	$ 11,372.000 Millions	$ 2,425 Millions
West Pharmaceutical Services Inc	4.69	$ 2,120.200 Millions	$ 452 Millions
Henry Schein Inc	4.63	$ 9,395.000 Millions	$ 2,031 Millions
Cryoport inc	4.60	$ 102.157 Millions	$ 22 Millions
Myomo Inc	4.58	$ 14.802 Millions	$ 3 Millions
Idexx Laboratories Inc	4.52	$ 1,743.379 Millions	$ 386 Millions
Autolus Therapeutics Plc	4.34	$ 88.293 Millions	$ 20 Millions
Medinotec Inc	4.28	$ 5.143 Millions	$ 1 Millions
Electromed Inc	4.18	$ 14.878 Millions	$ 4 Millions
Intelligent Bio Solutions Inc	4.14	$ 2.206 Millions	$ 1 Millions
3m Company	4.02	$ 15,267.000 Millions	$ 3,801 Millions
Novocure Limited	3.98	$ 166.721 Millions	$ 42 Millions
Sonoma Pharmaceuticals Inc	3.90	$ 14.275 Millions	$ 4 Millions
Koru Medical Systems Inc	3.88	$ 16.831 Millions	$ 4 Millions
Incyte Corporation	3.79	$ 439.399 Millions	$ 116 Millions
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Coherus Oncology inc	3.50	$ 16.193 Millions	$ 5 Millions
Exelixis Inc	3.49	$ 93.324 Millions	$ 27 Millions
Abbvie Inc	3.40	$ 17,346.000 Millions	$ 5,108 Millions
Gilead Sciences Inc	3.30	$ 6,219.000 Millions	$ 1,884 Millions
Iovance Biotherapeutics inc	3.21	$ 177.232 Millions	$ 55 Millions
Teva Pharmaceutical Industries Limited	3.16	$ 8,011.000 Millions	$ 2,537 Millions
Msa Safety Inc	3.00	$ 1,063.235 Millions	$ 354 Millions
Mimedx Group Inc	2.98	$ 70.562 Millions	$ 24 Millions

Date modified: 2026-11-06T12:56:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.